Comments for JNJ - Stockpickr! Your Source for Stock Ideas

Comments for JNJ

Added By	Comments	Type	Date Added
wm shell	Solid performer, Dividends	Love	November 05, 2009
Stockpickr Staff	On <a href="http://www.thestreet.com/story/10612174/2/cramers-mad-money-recap-take-charge-of-your-portfolio-final.html" target="_blank">"Mad Money" on Oct. 15</a>, Cramer said he'd been excited by J&J's earnings beat at first but had decided to put the stock in his Sell Block because the earnings were due to lowered R&D spending and a favorable tax rate. "That's not how we want to see companies make their numbers," he said.	Love	November 03, 2009
Shenaynay	Not a fast moving company but very solid and low risk, a good longterm investment that will pay rewards soon. Also right at the right price, buy now at 59 and you will get more $$$ Rating = B	Love	October 05, 2009
barrons3	What sectors might benefit from boomer consumers' continued strength? If The Graduate were made today, says Martin, "the cocktail party advice on the coming industry would shift from 'plastics' to 'probiotics.' Go into the aging businesses, all of which will thrive with longer life expectancies as the boomers age." Along with pharmaceuticals and other health-related goods and services, beauty products should do well. Procter & Gamble 's (PG) Olay, L'Oréal (LRLCY) and its Garnier unit and Johnson & Johnson 's (JNJ) Neutrogena have all launched products targeted to boomer women.	Love	October 03, 2009
barrons3	Johnson & Johnson (JNJ) is stalled, so is Pfizer (PFE). Same with Kraft (KFT).	Love	October 01, 2009
Stockpickr Staff	"Johnson & Johnson (JNJ) has purchased 14.6 million shares of Dutch biotech company Crucell (CRXL) for 301.8 million euros ($441 million)." <a href="http://www.thestreet.com/story/10603994/1/jj-buys-18-stake-in-biotech-firm-crucell.html" target="_blank">Read more here.</a>	Love	September 28, 2009
Eskimoman	They seem over rated and you con only make pennies on the stock.	Hate	September 20, 2009
Matrix99	everybody will need toiletries.	Love	September 17, 2009
KYHIghlander	it's $2 below where I bought it 8 years ago	Hate	September 17, 2009
barrons3	Not that I want us to be led by Merck (MRK) or by Johnson & Johnson (JNJ) -- it is just that the $3 spike in oil feels incredibly phony, just one of those oddities that seems entirely asset-class driven, not demand driven, a function of a falling dollar and money exiting toward a commodity that is not in that much demand.	Love	September 10, 2009
pickrr10	stability	Love	September 07, 2009
WLRowley	I like the things they make	Love	September 07, 2009
pfriedman	stable	Love	September 04, 2009
garretts415	solid	Love	August 30, 2009
bbauer	DIVIDEND/G&I	Love	August 27, 2009
k5861	Classic widow and orphan stock	Love	August 23, 2009
barrons3	It is not about the U.S. economy and what it means for factory orders to be up -- although conclusively (as my friend Matt Horween, he of the great series last week in the Opinion section on the flagship site, says) there were and are no jobs being created and the stimulus plan frankly isn't that kind of plan, good grief!). It is not about Procter & Gamble (PG) or Pepsi (PEP) or Johnson & Johnson (JNJ). It isn't even about Intel (INTC) and Microsoft (MSFT) and Cisco (CSCO). It certainly isn't about Apple (AAPL), Amazon (AMZN) and Google (GOOG), although there is some China expectation to the iPhone. Keep that in mind as everything comes down today.	Love	August 20, 2009
barrons3	Buffett is also raising his stake in Johnson & Johnson (JNJ), which has been slow to participate in the rally, Mike Khouw points out, suggesting the company might present a quality buying opportunity.	Love	August 19, 2009
Stockpickr Staff	"Lightning Round, Aug. 11: Johnson & Johnson (JNJ): "I swapped out of J&J in favor of Bristol-Myers Squibb (BMY) for my charitable trust but that doesn't mean I don't like J&J. It just means I like Bristol more given it's better yield."	Love	August 12, 2009
johnulu	VALUE	Love	August 08, 2009
LexTalionis	Good mix of solid core brands, innovation, and pursuit of new opportunities in health care.	Love	July 28, 2009
timzi	had success here	Love	July 22, 2009
madams07	Healthcare	Love	July 15, 2009
dobear	diversified	Love	July 14, 2009
Stockpickr Staff	<B>Johnson & Johnson</B>: J&J also reported its <a href="http://www.thestreet.com/story/10542464/1/jj-second-quarter-profit-tops-estimates.html" target="_blank"> second-quarter earnings today </a> and also beat analyst estimates. It posted profit of $3.2 billion, or $1.15 a share, down from $1.17 a share in the same quarter last year but above estimates for $1.11 a share. Sales fell 7.4% year over year to $15.2 billion. On June 18's <a href="http://www.thestreet.com/story/10519944/1/mad-money-lightning-round-stick-with-johnson-johnson.html" target="_blank">"Lightning Round" segment</a>, Cramer said that he liked J&J, calling it a "buy buy buy" and advising viewers to "stick with it."	Love	July 14, 2009
mblairocc	steady performer	Love	July 11, 2009
chrisn6179524	defensive, dividend	Love	July 11, 2009
mstaps	dividend	Love	July 07, 2009
alisona	Solid as a rock plus Buffett owns	Love	July 02, 2009
jsatter298	pharmaceutical	Love	June 25, 2009